纵向血浆代谢组学指导食管鳞状细胞癌化疗免疫治疗的动态风险评估与饮食调节
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.
Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
因此,我们推荐在 IHC 染色下使用 20 倍物镜识别 TB,并评估肿瘤旁的 TIL。此外,我们构建了一个列线图,以便于对 pT1b ESCC 患者进行个体化生存预测。
肿瘤出芽(TB)和TIL(肿瘤浸润淋巴细胞)是多种肿瘤中淋巴结转移(LNM)和不良预后的重要预测指标。目前,食管鳞状细胞癌(ESCC)中TB和TIL的评估尚无金标准。本研究旨在确定TB和TIL的评估标准,并构建pT1b ESCC患者预后的预测模型。
我们回顾性分析了150例pT1b ESCC病例中TB和TIL的预后价值。采用苏木精-伊红(H&E)染色和抗泛细胞角蛋白(AE1/AE3)免疫组化(IHC)分析TB的阈值,并使用受试者工作特征曲线(ROC)评估瘤内TIL和瘤周TIL(pTIL)。
我们发现,基于20倍物镜下的IHC染色,TB在三层分级系统中(低-TB:0-4;中-TB:5-15;高-TB:16)对LNM和生存显示出良好的预后预测。低pTIL水平(20%)是LNM和不良预后的显著指标(p < 0.05)。此外,较低的肿瘤位置和淋巴血管侵犯(LVI)与不良预后相关(p < 0.05)。基于TB、pTIL、LVI和肿瘤位置开发的列线图显示出良好的区分度,如ROC曲线下面积和校准曲线所示。
Tumor budding (TB) and tumor-infiltrating lymphocyte (TIL) are significant predictive indicators of lymph node metastasis (LNM) and unfavorable prognosis in various tumors. Currently, there is no gold standard for TB and TIL evaluation in esophageal squamous cell carcinoma (ESCC). This study aimed to identify the standard of TB and TIL evaluations and build a predictive model for prognosis among patients with pT1b ESCC.
We retrospectively analyzed the prognostic values of TB and TIL in 150 pT1b ESCC cases. Hematoxylin and eosin (H&E) and immunohistochemistry (IHC) of anti-pan cytokeratin (AE1/AE3) were used to analyze the threshold of TB, and intratumoral TIL and peritumoral TIL (pTIL) were evaluated using the receiver operating characteristic curves (ROC).
We found that TB in a three-tiered grading system (low-TB: 0-4; middle-TB: 5-15; high-TB: 16) displayed an excellent prognosis prediction for LNM and survival based on IHC staining using a 20 objective lens. Low pTIL level ( 20%) was a significant indicator of LNM and unfavorable prognosis (p < 0.05). Moreover, lower tumor location and lymphovascular invasion (LVI) were correlated with an unfavorable prognosis (p < 0.05). A nomogram developed based on TB, pTIL, LVI, and tumor location showed good discrimination, as shown by the area under the ROC and calibration curves.
We therefore recommend identifying TB using a 20 objective lens under IHC staining and TIL adjacent to the tumor. Additionally, a nomogram was built for facilitating individualized prediction of survival for patients with pT1b ESCC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。